Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes

BACKGROUND: Cellular transplantations have promising effects on treating spinal cord injury (SCI) patients. Mesenchymal stem cells (MSCs) and Schwann cells (SCs), which have safety alongside their complementary characteristics, are suggested to be the two of the best candidates in SCI treatment. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Oraee-Yazdani, Saeed, Akhlaghpasand, Mohammadhosein, Golmohammadi, Maryam, Hafizi, Maryam, Zomorrod, Mina Soufi, Kabir, Nima Mohseni, Oraee-Yazdani, Maryam, Ashrafi, Farzad, Zali, Alireza, Soleimani, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351425/
https://www.ncbi.nlm.nih.gov/pubmed/34372939
http://dx.doi.org/10.1186/s13287-021-02515-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351425/
https://www.ncbi.nlm.nih.gov/pubmed/34372939
http://dx.doi.org/10.1186/s13287-021-02515-2

Ejemplares similares